4//SEC Filing
Desjardins Clarissa 4
Accession 0001209191-20-003273
CIK 0001582313other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 2:34 PM ET
Size
5.4 KB
Accession
0001209191-20-003273
Insider Transaction Report
Form 4
Desjardins Clarissa
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-13+25,000→ 25,000 totalExercise: $16.42Exp: 2030-01-12→ Common Shares (25,000 underlying)
Footnotes (1)
- [F1]One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001793390
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 2:34 PM ET
- Size
- 5.4 KB